Home/Ictero Medical/Matthew Nojoomi, MSE
MN

Matthew Nojoomi, MSE

CEO, Co-Founder

Ictero Medical

Ictero Medical Pipeline

DrugIndicationPhase
CholeSafe SystemSymptomatic Gallstone Disease (Cholelithiasis)Pre-clinical